Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Receptor, Hormonal; Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00050011
What this trial is testing

Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy

Who this might be right for
Breast NeoplasmsOsteoporosis
Novartis Pharmaceuticals 602
Not applicableNot Yet RecruitingNCT06729099
What this trial is testing

Validity of Brain Metastasis Risk Predictive Model in Hormone Positive Breast Cancer Patients

Who this might be right for
Breast Cancer, Estrogen Receptor-Positive
Assiut University 128
Post-approval studies (Phase 4)UnknownNCT01072318
What this trial is testing

Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene

Who this might be right for
Breast Cancer
Korean Breast Cancer Study Group 495
Early research (Phase 1)Study completedNCT01197170
What this trial is testing

Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance

Who this might be right for
Solid TumorsAdvanced Cancer
M.D. Anderson Cancer Center 277
Testing effectiveness (Phase 2)Ended earlyNCT00918385
What this trial is testing

Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 57
Testing effectiveness (Phase 2)Study completedNCT00049062
What this trial is testing

Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
The University of Texas Health Science Center at San Antonio
Early research (Phase 1)Study completedNCT02599714
What this trial is testing

Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer

Who this might be right for
Advanced and Metastatic Breast Cancer
AstraZeneca 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT00585507
What this trial is testing

Efficacy and Safety of 500mg of Fulvestrant

Who this might be right for
Breast Cancer
Beth Israel Deaconess Medical Center 40
Testing effectiveness (Phase 2)Ended earlyNCT01616758
What this trial is testing

Phase II Study of GTx024 in Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
GTx 22
Post-approval studies (Phase 4)Not Yet RecruitingNCT07630948
What this trial is testing

Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer

Who this might be right for
Breast CancerAdherence, Medication
Institute of Oncology Ljubljana 90
Testing effectiveness (Phase 2)Ended earlyNCT00194792
What this trial is testing

Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerProgesterone Receptor-positive Breast Cancer+3 more
University of Washington 28
Not applicableUnknownNCT03873428
What this trial is testing

Evaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With FES

Who this might be right for
FES TEP in Detection of Estrogen Receptors
Centre Georges Francois Leclerc 25
Early research (Phase 1)Looking for participantsNCT07137871
What this trial is testing

Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy

Who this might be right for
Breast Cancer Metastatic
The University of Texas Health Science Center at San Antonio 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT02971748
What this trial is testing

Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

Who this might be right for
Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Breast Inflammatory Carcinoma+2 more
M.D. Anderson Cancer Center 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04639986
What this trial is testing

Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Gilead Sciences 331
Testing effectiveness (Phase 2)Active Not RecruitingNCT06702618
What this trial is testing

Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 33
Testing effectiveness (Phase 2)UnknownNCT03024580
What this trial is testing

A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer

Who this might be right for
Breast Neoplasm
Instituto Nacional de Cancer, Brazil 20
Not applicableStudy completedNCT03860740
What this trial is testing

Effect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer Patients

Who this might be right for
Breast CancerLuminal B
Spanish Breast Cancer Research Group 12
Post-approval studies (Phase 4)Study completedNCT00237133
What this trial is testing

Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women

Who this might be right for
Locally Advanced Breast Cancer
Novartis Pharmaceuticals 112
Post-approval studies (Phase 4)Study completedNCT01755572
What this trial is testing

Blood Pressure Outcomes With Liraglutide Therapy

Who this might be right for
Type 2 DiabetesSystolic Hypertension
Mount Sinai Hospital, Canada 22
Next Page